scispace - formally typeset
C

Carmen Alvarez-Lorenzo

Researcher at University of Santiago de Compostela

Publications -  388
Citations -  16274

Carmen Alvarez-Lorenzo is an academic researcher from University of Santiago de Compostela. The author has contributed to research in topics: Self-healing hydrogels & Drug delivery. The author has an hindex of 61, co-authored 359 publications receiving 13507 citations. Previous affiliations of Carmen Alvarez-Lorenzo include Massachusetts Institute of Technology & Saarland University.

Papers
More filters
Journal ArticleDOI

Light-sensitive intelligent drug delivery systems.

TL;DR: In this review, the mechanisms used to develop polymeric micelles, gels, liposomes and nanocomposites with light‐sensitiveness are analyzed and the potential of light‐sensitive carriers as functional components of intelligent DDS is discussed.
Journal ArticleDOI

Crosslinked ionic polysaccharides for stimuli-sensitive drug delivery.

TL;DR: The state of the art of crosslinked ionic polysaccharides as components of delivery systems that can regulate drug release as a function of changes in pH, ion nature and concentration, electric and magnetic field intensity, light wavelength, temperature, redox potential, and certain molecules are analyzed.
Journal ArticleDOI

Molecularly imprinted polymers for drug delivery

TL;DR: This review seeks to highlight the more remarkable advantages of the imprinting technique in the development of new efficient DDS as well as pointing out some possibilities to adapt the synthesis procedures to create systems compatible with both the relative instable drug molecules and the sensitive physiological tissues with which MIP-based DDS would enter into contact when administered.
Journal ArticleDOI

Smart drug delivery systems: from fundamentals to the clinic.

TL;DR: A critical overview of therapeutically-interesting stimuli to trigger drug release and the evolution of responsive materials suitable as functional excipients is offered, illustrated with recent examples of formulations in clinical trials or already commercially available, which can provide a perspective on the current state of the art on smart drug delivery systems.
Journal ArticleDOI

Ocular release of timolol from molecularly imprinted soft contact lenses

TL;DR: Results indicate that imprinted soft contact lenses are promising drug devices able to provide greater and more sustained drug concentrations in tear fluid with lower doses than conventional eyedrops.